A Mixture Experiment Approach for Controlling the Dissolution Rate of a Sustained-Release Tablet

1998 ◽  
Vol 24 (9) ◽  
pp. 799-806 ◽  
Author(s):  
Jean-Marie Geoffroy ◽  
Jennifer K. Fredrickson ◽  
John T. Shelton
Keyword(s):  
Sustained Release ◽  
Dissolution Rate ◽  
Sustained Release Tablet ◽  
Mixture Experiment ◽  
Release Tablet

Scintigraphic assessment of the in vivo dissolution rate of a sustained release tablet

1982 ◽  
Vol 10 (1) ◽  
pp. 17-24 ◽  
Author(s):  
P.B. Daly ◽  
S.S. Davis ◽  
M. Frier ◽  
J.G. Hardy ◽  
J.W. Kennerley ◽  
...  
Keyword(s):  
Sustained Release ◽  
Dissolution Rate ◽  
Sustained Release Tablet ◽  
Scintigraphic Assessment ◽  
Release Tablet ◽  
In Vivo Dissolution

scholarly journals Effect of Particle Size of HPMC on Dissolution Rate of Venlafaxine HCl and Carbamazepine Sustained Release Tablet

Polymer Korea ◽  
2012 ◽  
Vol 36 (3) ◽  
pp. 332-337
Author(s):  
Jae-Uk Cha ◽  
Ja-Hyun Cha ◽  
Jun-Kee Hong ◽  
Sung-Wan Lee ◽  
Won-Hwa Ko ◽  
...  
Keyword(s):  
Particle Size ◽  
Sustained Release ◽  
Dissolution Rate ◽  
Sustained Release Tablet ◽  
Effect Of Particle Size ◽  
Release Tablet

Sustained release tablet formulation of diethylcarbamazine. Part II

1985 ◽  
Vol 24 (2-3) ◽  
pp. 355-358 ◽  
Author(s):  
S.K. Baveja ◽  
K.V. Ranga Rao ◽  
Rajinder Kumar ◽  
K. Padmalatha Devi
Keyword(s):  
Sustained Release ◽  
Tablet Formulation ◽  
Sustained Release Tablet ◽  
Release Tablet

DESIGN DEVELOPMENT AND OPTIMIZATION OF A SUSTAINED RELEASE TABLET OF BOSENTAN MONOHYDRATE FOR PULMONARY ARTERIAL HYPERTENSION

INDIAN DRUGS ◽  
2019 ◽  
Vol 56 (03) ◽  
pp. 61-67
Author(s):  
P. P Dighe ◽  
H. M Tank ◽  
Keyword(s):  
Pulmonary Arterial Hypertension ◽  
Sustained Release ◽  
Arterial Hypertension ◽  
In Vitro Release ◽  
Design Development ◽  
23 Factorial Design ◽  
Sustained Release Tablet ◽  
Pulmonary Arterial ◽  
Release Tablet

Pulmonary arterial hypertension (PAH) means high blood pressure in the lungs caused by obstruction in the small arteries of the lungs.The current study involves the fabrication of oral matrix sustained release tablet of bosentan monohydrate, a dual endothelin receptor antagonist, the optimisation of its in vitro release and characterisation. Methocel K4M PremiumDC2, a directly compressible HPMC grade, has been used as the sustained release polymer. Pregelatinised starch is used as a diluent and release modifier and sodium lauryl sulphate as a solubiliser. The influence of the above variables on drug release is measured using a 23 factorial design using design expert software. Surface response plots show significant interaction among the formulation variables, thus aiding in optimization of bilayer tablet.

scholarly journals Preparation and Evaluation of Nifedipine sustained release Tablet by using Natural Gums as release retardant

2014 ◽  
Vol 01 (03) ◽  
pp. 78-84 ◽  
Author(s):  
Gayatri D Medisetty ◽  
Girish B Botta ◽  
Uma maheshwari Yamana ◽  
Ashwini Avasarala
Keyword(s):  
Sustained Release ◽  
Sustained Release Tablet ◽  
Preparation And Evaluation ◽  
Release Tablet

Novel Chewable Sustained‐Release Tablet Containing Verapamil Hydrochloride

2004 ◽  
Vol 9 (2) ◽  
pp. 181-188 ◽  
Author(s):  
Omaima N. El‐Gazayerly ◽  
Vipaporn Rakkanka ◽  
James W. Ayres
Keyword(s):  
Sustained Release ◽  
Verapamil Hydrochloride ◽  
Sustained Release Tablet ◽  
Release Tablet

Pharmacokinetics of Pentoxifylline after Oral Administration of a Sustained Release Tablet at Two Different Times of the Day

2011 ◽  
Vol 49 (09) ◽  
pp. 750-753
Author(s):  
Poondru Srinivasu ◽  
Devraj Rambhau ◽  
Boinpally Rao ◽  
Yamsani Rao
Keyword(s):  
Sustained Release ◽  
Oral Administration ◽  
Sustained Release Tablet ◽  
Release Tablet
Sign in / Sign up

Export Citation Format

Share Document